American College of Cardiology 71st Scientific Sessions: Science Preview, April 4, 2022

News
Slideshow

At ACC 2022 on Sunday, 4-2, look for studies on icosapent ethyl and alirocumab, landmark research on HFrEF, and a novel anticoagulant for atrial fibrillation.

On the final day of ACC 2022, check out late-breaking clinical trials during 3 different sessions.

A few higlights: Edoxaban vs DAPT post-TAVR, finerenone and cardiorenal outcomes in special CVD populations, canakinumab and residual inflammatory risk, and a report on an international ACC program to improve treatment for STEMI.

Saturday, April 2, 2022 Late Breaking Clincial Trials

Sunday, April 3, 2022 Late Breaking Clincial Trials

More News from ACC on Patient Care

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data

Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data

Grace Halsey
June 23rd 2025
Article

Weight cycling significantly raises heart failure and metabolic disease risks, independent of baseline overweight, underscoring the importance of stable weight strategies.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose / image credit: ©New Africa/AdobeStock

Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose

Sydney Jennings
June 19th 2025
Article

Your daily dose of the clinical news you may have missed.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

/ image credit Cathy Goldstein, MD Courtesy of Michigan Neuroscience Institute

Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announces

Grace Halsey
June 18th 2025
Article

Huxley Medical's SANSA home sleep apnea test matched traditional PSG in accuracy and significantly simplifies OSA assessment and diagnosis for patients and HCPs.

Universal Low-Dose Aspirin Prescribing Strategy May be Beneficial for Preeclampsia Prevention

Universal Low-Dose Aspirin Prescribing Strategy May be Beneficial for Preeclampsia Prevention

Sydney Jennings
June 18th 2025
Article

Research presented at ACOG 2025 showed 99% of pregnant women included in the analysis were eligible for aspirin, per ACOG guidelines.

© 2025 MJH Life Sciences

All rights reserved.